Zobrazeno 1 - 10
of 69
pro vyhledávání: '"P. D. Minor"'
Autor:
Philip D. Minor
Publikováno v:
Vaccines, Vol 3, Iss 1, Pp 90-104 (2015)
The potency of vaccines must be determined to ensure that the appropriate dose is given. The manufacture and assessment of influenza vaccines are complicated by the continuously changing nature of the pathogen, which makes efficacy estimates difficul
Externí odkaz:
https://doaj.org/article/1055a6e17a9a4fea8d263dc04161274a
Publikováno v:
PLoS Pathogens, Vol 13, Iss 1, p e1006117 (2017)
While wild type polio has been nearly eradicated there will be a need to continue immunisation programmes for some time because of the possibility of re-emergence and the existence of long term excreters of poliovirus. All vaccines in current use dep
Externí odkaz:
https://doaj.org/article/ec64f0bcad1a4b05892bda4ea3237b01
Publikováno v:
PLoS Pathogens, Vol 11, Iss 12, p e1005316 (2015)
Poliomyelitis has nearly been eradicated through the efforts of the World Health Organization's Global Eradication Initiative raising questions on containment of the virus after it has been eliminated in the wild. Most manufacture of inactivated poli
Externí odkaz:
https://doaj.org/article/9426b35ba9c842b3a3b5ba2f51166bc1
Publikováno v:
PLoS Pathogens, Vol 11, Iss 8, p e1005114 (2015)
There are currently huge efforts by the World Health Organization and partners to complete global polio eradication. With the significant decline in poliomyelitis cases due to wild poliovirus in recent years, rare cases related to the use of live-att
Externí odkaz:
https://doaj.org/article/f6721bd7b9ce49228e25d08168420c8f
Autor:
Giada Mattiuzzo, James Ashall, Kathryn S Doris, Kirsty MacLellan-Gibson, Carolyn Nicolson, Dianna E Wilkinson, Ruth Harvey, Neil Almond, Robert Anderson, Stacey Efstathiou, Philip D Minor, Mark Page
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142751 (2015)
The 2013-present Ebola virus outbreak in Western Africa has prompted the production of many diagnostic assays, mostly based on nucleic acid amplification technologies (NAT). The calibration and performance assessment of established assays and those u
Externí odkaz:
https://doaj.org/article/efcff35a8d694740a5cd3c51e4f3d362
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 1, Pp 151-154 (2006)
We report a novel parvovirus (PARV4) and related variants in pooled human plasma used in the manufacture of plasma-derived medical products. Viral DNA was detected by using highly selective polymerase chain reaction assays; 5% of pools tested positiv
Externí odkaz:
https://doaj.org/article/d546de04808f4b8395303e5880534233
Autor:
P D Minor
Publikováno v:
British Medical Bulletin. 62:213-224
Eradication of disease requires the eradication of the causative agent. Smallpox is the only human disease knowingly eradicated so far and, while poliomyelitis is likely to be the second, they present very different problems. All smallpox infections
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34cd6d8500f1b4d9d6a3bcadfe270258
https://doi.org/10.1093/bmb/62.1.213
https://doi.org/10.1093/bmb/62.1.213
Autor:
P. D. Minor, J. Almond
Publikováno v:
Molecular Biology of Picornavirus
The pathogenesis of poliomyelitis is central to understanding the effectiveness of the vaccines that are likely to eradicate the wild-type virus from the world over the next few years. Studies of the molecular biology of the Sabin live polio vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd6e3ea01cb25c5afe29718c0cfdac89
https://doi.org/10.1128/9781555817916.ch30
https://doi.org/10.1128/9781555817916.ch30
Autor:
P. M. Mannucci, Christine A. Lee, F. Rossi, Erik Berntorp, Evelien P. Mauser-Bunschoten, John A. Penner, Trevor W. Barrowcliffe, Robert C. Miller, Louis M. Aledort, Bruce M. Ewenstein, Craig M. Kessler, Christopher A. Ludlam, A. Srivastava, Simon A. Brown, Pia Petrini, P. D. Minor
Publikováno v:
Haemophilia. 6:125-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e9d00e475f6165516382d6465c4ac0b
https://doi.org/10.1046/j.1365-2516.2000.00408.x
https://doi.org/10.1046/j.1365-2516.2000.00408.x
Autor:
Richard M. Kaufman, N.A. Clarkson, P.A. Pipkin, Jeffrey W. Almond, David J.A. Evans, Trevor Ward, D M Lublin, P D Minor
Publikováno v:
Journal of Virology. 69:5497-5501
CD55, or decay-accelerating factor (DAF), is a cell surface glycoprotein which regulates complement activity by accelerating the decay of C3/C5 convertases. Recently, we and others have established that this molecule acts as a cellular receptor for e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c030766dc49b1c3e8085a71228192a
https://doi.org/10.1128/jvi.69.9.5497-5501.1995
https://doi.org/10.1128/jvi.69.9.5497-5501.1995